How early planning leads to successful market access and drug launch in Europe
Pharmaceutical Technology
FEBRUARY 7, 2023
An example is NICE’s Quality Adjusted Life Year score, used to price drugs in the UK. Some nations such as France base their decisions on the drug’s medical benefit and clinical added value versus existing therapies. Overall, it is never too soon to begin market access activities, but it can easily be too late.
52 
Let's personalize your content